Published in
Elsevier, The Lancet, 10120(391), p. 552-562
DOI: 10.1016/s0140-6736(17)33105-7
Links
Tools
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Journal article published in 2018 by
Martin R. Gaudinski,
Kathryn Zephir,
Katherine V. Houser,
Kaitlyn M. Morabito 
,
Zonghui Hu,
Galina Yamshchikov,
Ro Shauna Rothwell,
Nina Berkowitz,
Floreliz Mendoza,
Jamie G. Saunders,
Laura Novik,
Cynthia S. Hendel,
LaSonji A. Holman,
Ingelise J. Gordon,
Josephine H. Cox
and other authors.
,
Zonghui Hu,
Galina Yamshchikov,
Ro Shauna Rothwell,
Nina Berkowitz,
Floreliz Mendoza,
Jamie G. Saunders,
Laura Novik,
Cynthia S. Hendel,
LaSonji A. Holman,
Ingelise J. Gordon,
Josephine H. Cox
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 